Loading company…
Mind-NRG develops treatments for neurological and psychiatric disorders.
Founded in 2010 and based in Switzerland, Mind-NRG develops treatments for neurological and psychiatric disorders. Its NRG-101 neurotrophic factor is described as crossing the blood-brain barrier through receptor-mediated transport.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in